Workflow
Biotech
icon
Search documents
X @Wu Blockchain
Wu Blockchain· 2025-10-17 10:50
Program Overview - YZi Labs launches the second season of EASY Residency incubation program [1] - The program is an eight-week initiative [1] - The program focuses on global collaboration among entrepreneurs in Web3, AI, and Biotech [1] Focus Areas - The program covers areas such as stablecoins and payments [1] - The program covers Web3 creator tools [1] - The program covers agentic AI [1] - The program covers gene therapy [1]
X @CZ 🔶 BNB
CZ 🔶 BNB· 2025-10-17 09:51
Company Overview - YZi Labs 推出 @EASYResidency 第二季,专注于 Web3、AI 和生物科技领域的创始人 [1] - 该项目历经七年筹备,现已在全球四个城市启动 [1] Program Focus - @EASYResidency 旨在帮助 Web3、AI 和生物科技领域的创始人构建无国界的事业 [1] Event Highlight - 官方发布了开幕日的回顾 [1]
Tech billionaires' ramp up bets on AI, biotech
CNBC Television· 2025-10-15 17:36
Investment Trends - Family offices direct deals in startups decreased by 46% year-over-year in Q3 [1] - Only 169 investments by family offices were recorded in Q3 [2] - AI, biotech, and energy were the primary sectors of interest for family office deals [1] - Peter Thiel's family office made seven investments in the quarter, including a $100 million funding round for Decart, an Israeli AI firm valued at $3 billion [2] - Michael Dell's family office invested in Harbor Health, a clinic health insurance company based in Austin [3] - Jeff Bezos and Eric Schmidt invested alongside Nvidia in a $300 million seed round for Periodic Labs, which aims to create AI scientists [4] Market Dynamics - The AI investment space is becoming crowded, making it challenging for family offices to find suitable investment opportunities [5] - Increased competition in AI fundraising and private capital is limiting the availability of large-scale private companies for investment [5] - High valuations and difficulty in accessing deals are emerging as challenges for family offices in the current environment [6]
Billionaires bet on AI, biotech: Here's what to know
CNBC Television· 2025-10-15 11:15
Right now for a read on where some of America's wealthiest individuals are putting their money, we are joined by Robert Frank. Robert, good morning. Good to good to see all of you.Uh for family offices, deals in the third quarter were all about AI, biotech, and energy. Direct deals by family offices and startups fell 46% in the third quarter. That compares to a year ago.That's according to exclusive data from FINRIX. Now, there were only 169 investments recorded by family offices in the quarter. The tech bi ...
Hong Kong poised for greater role in Islamic finance, financial secretary says
Yahoo Finance· 2025-10-13 09:30
Core Viewpoint - Hong Kong is positioning itself as an Islamic finance hub in North Asia, with increasing interest from companies in issuing sukuk bonds to attract Middle Eastern capital into the Greater Bay Area [1][2]. Group 1: Sukuk Bonds and Market Infrastructure - There has been a notable rise in inquiries from companies regarding the issuance of sukuk bonds in Hong Kong, indicating potential future transactions [2]. - Hong Kong possesses a "world-class financial market infrastructure and deep capital markets," making it an ideal conduit for Islamic capital into mainland China [2]. - The city has a legal framework supporting the issuance of sukuk and other sharia-compliant instruments, with the government having issued over US$3 billion in sukuk a decade ago [3]. Group 2: Recent Developments in Islamic Finance - In November 2023, Hong Kong launched Asia's first exchange-traded fund (ETF) tracking the largest companies in Saudi Arabia, alongside an ETF for sukuk government bonds listed earlier in the year [4]. - Last year, two Hong Kong stock ETFs were also listed in Saudi Arabia, showcasing the growing integration of Hong Kong's financial market with Islamic finance [4]. Group 3: Government Initiatives and International Collaboration - The Financial Secretary of Hong Kong plans to lead a delegation to Saudi Arabia, focusing on sectors such as artificial intelligence, biotech, fintech, and green energy, to bolster Islamic finance and cross-border financial products [5]. - Standard Chartered has been actively assisting clients in issuing sukuk globally, including the sukuk issued by the Hong Kong government ten years ago [5].
Cathie Wood sells shares in major AI stock
Yahoo Finance· 2025-10-12 17:07
Core Insights - Cathie Wood's ARK Invest continues to attract investors due to its focus on disruptive innovation, particularly in AI, fintech, and biotech, despite the inherent volatility in these sectors [1][2] - ARK's flagship innovation fund has achieved a significant double-digit gain this year, outperforming the S&P 500, although it has experienced higher volatility compared to the index [2] - Recent portfolio adjustments indicate a strategic shift towards fintech and automation, with a notable reduction in exposure to Palantir Technologies [3][5] Company and Industry Summary - ARK Invest has trimmed its stake in Palantir Technologies by selling approximately 4,000 shares valued at $754,000, reflecting a cautious approach as AI valuations have surged [5] - The fund's top holdings include Tesla (9.94%), Coinbase (4.87%), Roku (4.66%), Shopify (4.62%), and Palantir (4.60%), among others, showcasing a concentrated investment strategy [4] - In addition to reducing its position in Palantir, ARK has increased its investments in fintech, acquiring 1.2 million shares of LY Corp. and expanding its stake in Klarna Group by 76,000 shares [6] - Other notable reductions include selling 9,100 shares of Roblox for nearly $1.15 million and 18,300 shares of Shopify across multiple ARK funds, totaling around $3 million [7]
X @Nick Szabo
Nick Szabo· 2025-10-11 01:47
RT Douglas Yao (@DouglasYaoDY)CRISPR came from yogurt bacteria. GLP-1s came from Gila monster venom. Taq polymerase came from hot spring bacteria.As much as we like to think that progress in biotech is driven by human design, our biggest breakthroughs over the years have all originated from nature. ...
X @Forbes
Forbes· 2025-10-08 10:00
Company Overview - A 60-year-old drug developer built a $4.4 billion biotech company [1] - The company focuses on treating 'Butterfly Skin Disease' (大疱性表皮松解症) [1]
YZi Labs Introduces $1B Fund for BNB Chain Projects
Yahoo Finance· 2025-10-08 09:29
Core Insights - YZi Labs has launched a $1 billion fund aimed at supporting projects on the BNB Chain, focusing on areas such as trading, real-world assets, artificial intelligence, decentralized finance, and wallets [1][2] Group 1: Investment Focus - The fund is designed to foster the BNB ecosystem, promoting democratized access and ownership, enhancing human potential through AI, and improving quality of life via biotech [2] - YZi Labs is committed to supporting builders in sectors like DeFi, AI, RWA, and DeSci, aiming to create open systems that connect technology to human progress [2] Group 2: Company Background - YZi Labs was rebranded from the venture arm of Binance and is often referred to as Changpeng "CZ" Zhao's family office, although it operates differently from traditional family offices [3][4] - Following Zhao's release from prison, he has taken a more active role in the company's venture capital initiatives, targeting startups in Web3, AI, and biotech [3]
Sanofi (SNY) Invests $625 Million in Sanofi Ventures
Yahoo Finance· 2025-10-05 06:42
Core Insights - Sanofi is recognized as one of the best and undervalued stocks to buy currently, with a recent announcement of a $625 million investment in Sanofi Ventures, raising total assets to over $1.4 billion [1][2]. Investment Strategy - The additional investment supports Sanofi Ventures' long-term focus on biotech and digital health startups, which was founded in 2012 and has invested over $800 million in approximately 70 companies globally [2]. - Sanofi Ventures invests in companies at all stages, from early seed funding to IPOs, and provides support by participating on boards and assisting in exits [2]. Company Overview - Sanofi is a global healthcare company based in France, engaged in the research, development, manufacturing, and marketing of medicines, vaccines, and consumer healthcare products [3].